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ABSTRACT
There is clear indication that prehypertension is the state of persistent blood pressure of being (120-139 mmHg/80-89 mmHg) or named 
pseudohypertension is a significant marker that certainly progresses to develop incident hypertension >140-159/80-89 that causes cardiovascular 
risk. Therefore, it became essential to prevent this progression so that incident hypertension is precluded, but it is brainy if we research on the 
independent harmful effects of this pre-hypertension on the body system and therefore be aware of possible interventional impingement salvage 
effectively to the body system in the absence of cardiovascular or other secondary disease. Thus, this mini review will explore all the relevant literature 
evolved to help independently associated harmful effect of pre-hypertension in body functioning in the absence of comorbid status.
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INTRODUCTION
Seventh Report of the Joint National Committee (JNC-7) included the 
term pre-hypertension by giving the range of blood pressure (BP) 
120-139/80-89, but it is very necessary to do operation in that whether 
this BP does have independent harmful effects in the body system as 
Huang et al.[1] challenged the guideline system by documenting that 
pre-hypertension (even at lower levels of 120-129/80-84 mmHg) is a 
significant cardiovascular risk factor [2].
PRE-HYPERTENSION DEREGULATES AUTONOMIC NERVOUS 
SYSTEM
One literature gave the categorized proposition of pre-hypertension into 
stage 1 pre-hypertension BP ranging from 120 to 129 mmHg/80-84, 
and diastolic BP (DBP), also stage 2 pre-hypertension with BP 
130-139/85-89 mmHg [3]. Peak heart rate subtracted heart rate 
measured after 2 minutes of respite is called heart rate recovery 
(HRR), one of the simple non-invasive measurement technique for 
investigation of integrity of autonomic nervous system and its effect on 
cardiovascular system, this measure has shown to predict the mortality 
of cardiovascular risk, report has documented that delayed HRR is 
independently associated with pre-hypertension [3], the measure of 
autonomic nervous system activity that plays a crucial role in regulation 
of BP [4].
MECHANISM OF DELAYED HRR ASSOCIATED CARDIOVASCULAR 
DISEASE (CVD) MORTALITY
Genesis of cardiac autonomic regulatory dysfunction is one of the 
primary causes linked to CVD and mainstay of mortality in CVD 
patient; the assessment of cardiac autonomic dysfunction gives an 
idea to have cardiac autonomic activity and is carried out by HRR, 
a noninvasive quantification method of heart rate decrement after 
exercise, a powerful index of predicting mortality. The HRR phase 
comprises two components fast and slow, earlier is dictated by 
parasympathetic reactivation possibly invoked by the deactivation 
of central command and mechanoreflex inputs immediate after 
stopping of exercise. On the other hand, the slow phase of HRR may 
be set by cardiac sympathetic withdrawal, possibly through the 
inactivation of muscle afferent signaling that increased sympathetic 
discharge and thermoregulatory mechanisms. All these pathways 
look impaired in CVD, bolstering to explain the slower HRR in these 
patients, and the raise the rate of mortality in individuals who 
present a slower HRR [5,6].
PRE-HYPERTENSION IS INDEPENDENTLY ASSOCIATED WITH 
MICROALBUMINURIA LESS TO HYPERURICEMIA
Pre-hypertension (BP: Systolic, 130-139 mmHg or diastolic, 
85-89 mmHg) has higher cardiovascular risks compared with 
normal BP (systolic BP [SBP], 120-129 mmHg or DBP, 80-84 mmHg). 
Albumin in urine indicates leakage from blood vessel possibly due 
to generalized vascular damage, many clinical condition measures 
the concentration of urinary albumin excretion and termed as 
microalbuminuria if excretion is in the range of 30-300 mg/24 hrs 
and is the prognostic indicator of cardiovascular risk and progression 
of kidney damage [7-9], this index that investigation of urine albumin 
should be done even in pre-hypertensive. A study conducted in Chinese 
women after excluding patient with diabetes, hyperuricemia, or under 
hypertensive medication, and the assessment is made by comparing 
pre-hypertensive with microalbuminuria with normotensive found 
that pre-hypertensive were more likely to have microalbuminuria and 
concluded that microalbuminuria is independently associated with pre-
hypertension among Chinese women [10]. Multiple logistic regression 
analysis showed that the high normal BP category had an independently 
significant association with microalbuminuria [11], considered to be 
the reflection of endothelial dysfunction. Epidemiological reports that 
revealed serum uric acid level is linked with CVD more strongly in 
hypertension stage, a study has demonstrated that pre-hypertension 
is less relatively associated with hyperuricemia 1.4% versus 1.7%, but 
microalbuminuria 4.0% versus 7.9% in normotensive group and pre-
hypertensive group [12-15].
Cardiovascular event is one of the life-threatening fatal conditions, the 
marker of which is essential to recognize, as pre-hypertension does 
cause cardiovascular risk and microalbuminuria, the identified marker 
of cardiovascular event which can direct intensive therapy [16,17].
A study documented that prehypertension is even not associated 
hyperuricemia but associated with purine-rich food [18], but other 
study presented vice versa report elucidating that the association of 
serum uric acid increases risk of prehypertension [17].
PRE-HYPERTENSION CAUSES CARDIAC AND VASCULAR 
PATHOLOGY
The JNC-7 on Prevention, Detection, Evaluation, and Treatment of High 
BP (JNC-7), introduced the terms pre-hypertension and defined the 
terminology as a condition persistent sustained remnant of BP at the 
range of 120-139/80-89 SBP and DBP, respectively [18]. Chronically, it 
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has effect in different body system, and one study made in Southern 
China reported that in middle and elderly aged people levied 
independently with carotid atherosclerotic plaque generation, that 
causes ischemic stroke, Further to say, pre-hypertension is a warning 
status of CVD; therefore, it should be carefully monitored and strategy 
of lifestyle modification should adopted to minimize a predisposing 
factor of CVD and stroke [19]; the detrimental effects are on functional 
and anatomical structure cardiovascular integrity bringing it into 2-fold 
risk compared to normotensive individual, this observatory conclusion 
is made on the basis of a study that involved 375 participants that 
exhibited higher left ventricular wall thickness (pre-hypertensive, 0.78 
and normotensive 0.72 cm), left ventricular mass 161 versus 137 g, and 
relative wall thickness 0.29 versus 0.28 cm thickness [20].
CONCLUSION
Pre-hypertension has a greater risk of CVD including microalbuminuria 
hyperuricemia to a lesser extent and autonomic dysfunction, indulge 
in hemodynamic and cardiac functioning than those with normal 
BP. Further investigations are needed to ascertain whether more 
deleterious effects are independently linked besides aforementioned.
Moreover, the participants with increased BPs should get medical 
treatment to prevent the effects on different body system such as 
vascular structure and myocardium even in pre-hypertensive phase.
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